Showing results (471-480 of 604) with videos related to
Sort By:
Pageof 61
RMD Open|March 17, 2022
Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group RegistryXavier Puéchal, Michele Iudici, Christian Pagnoux, et al.Annals of the Rheumatic Diseases|March 18, 2026
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST scoreAnn-Christin Pecher, Marouane Boubaya, Yannick Allanore, et al.European Journal of Cancer (Oxford, England : 1990)|November 23, 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment studyMarion Panhaleux, Olivier Espitia, Benjamin Terrier, et al.Annals of Emergency Medicine|March 6, 2018
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled TrialNicolas Javaud, Olivier Fain, Isabelle Durand-Zaleski, et al.Annals of the Rheumatic Diseases|February 2, 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR databaseQingran Yan, Cosimo Bruni, Alexandru Garaiman, et al.Journal of Internal Medicine|November 28, 2023
Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohortKevin Chevalier, Benjamin Thoreau, Marc Michel, et al.Plos One|September 15, 2015
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, et al.Rheumatology (Oxford, England)|September 20, 2021
Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group RegistryMichele Iudici, Christian Pagnoux, Delphine S Courvoisier, et al.British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.Diagnostics (Basel, Switzerland)|February 10, 2024
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research DatabaseGemma Lepri, Cosimo Bruni, Lorenzo Tofani, et al.Pageof 61